Rosuvastatin Calcium CAS 147098-20-2

Rosuvastatin Calcium CAS 147098-20-2
Product Details
Our business has strived to establish a highly efficient and stable team staff and explored an effective good quality regulate course of action for Guaifenesin DC95, 5-nitroisophthalic Acid Dimethyl Ester, 98-96-4. Our company has a long-term and stable cooperative relationship with many companies. The product variety is complete and the price is reasonable. Our company is strong, trustworthy, and has won the trust of customers with the principle of quality first. We hope to build a team cohesion that integrates everyone, gather the strengths and ability of the employees to keep moving forward. We has now developed into a professional, branded and industrialized company. Our company has been committed to the research and development of new products, in order to better serve the majority of customers.

API:Rosuvastatin Calcium

CAS NO:147098-20-2

Therapeutic Category:Cadiovascular drug

Availability:Under development

We are a professional and competitive rosuvastatin calcium manufacturer and supplier in China. All products we supply are in line with cGMP standard and approved by SFDA(China FDA), US-FDA and EDQM respectively. Please rest assured to place orders.

We are committed to integrity and service. In the future, we will cherish the trust of customers, continue to optimize products and improve service levels, and return customers with high-quality Rosuvastatin Calcium CAS 147098-20-2. Since the establishment of the company, we have continued to develop new products and improve product quality in an aggressive, active and innovative attitude. After years of continuous efforts, our products are sold well at home and abroad. We have established a quality assurance system to ensure that the manufacturing and sales processes are under control.
Hot Tags: rosuvastatin calcium, China, manufacturer, supplier, supply, cGMP, competitive, high quality, 1955-46-0, 60239-18-1, 90536-66-6, 3-chloro-1,2-propanediol, 294-90-6, Cyclen
Feedback

You Might Also Like